top of page
WhatsApp Image 2026-10-22 at 11.59.00.jpeg

Annual Reports

Our Annual Reports

Click on the links below to download our Annual Reports

StemSmart™: Advancing Stem Cell Therapy

A patented, high-quality platform for immune disease treatment

StemSmart™ is a globally patented technology designed to enhance the safety and efficacy of mesenchymal stem cell (MSC) therapies. Manufactured under GMP standards with a TGA product manufacturing licence, StemSmart™ products are consistently produced using a proprietary process that primes cells for stronger responses to inflammation. Early Phase 2 trial results in refractory Crohn’s disease indicate StemSmart™ MSC is potent, efficacious, and safe.

bottom of page